Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes

David Aguilar1, Biykem Bozkurt, Kumudha Ramasubbu

  • 1Winters Center for Heart Failure Research and Section of Cardiology, Department of Medicine, Baylor College of Medicine, 1709 Dryden Street-BCM 620, Suite 500, Box 13, Houston, Texas 77030, USA. daguilar@bcm.edu

Insights

Glycosylated hemoglobin (HbA1C) levels show a U-shaped association with mortality in diabetic patients with heart failure (HF). Optimal outcomes were observed with modest glucose control, suggesting a need for personalized treatment goals.

Area of Science:

  • Cardiology
  • Endocrinology
  • Geriatrics

Background:

  • Diabetes mellitus and heart failure (HF) frequently coexist.
  • Previous research on the association between glycosylated hemoglobin (HbA1C) and adverse outcomes in diabetic patients with HF has yielded inconsistent results.
  • This study addresses the limited and conflicting data by examining HbA1C's impact on mortality and HF hospitalizations.

Purpose of the Study:

  • To investigate the relationship between glycosylated hemoglobin (HbA1C) levels and adverse clinical outcomes in a cohort of diabetic patients with established heart failure (HF).
  • To determine if specific HbA1C ranges are associated with increased risk of death or HF hospitalization.
  • To identify potential optimal glycemic control targets for patients with both diabetes and HF.

Main Methods:

  • A retrospective analysis was conducted on a national cohort of 5,815 veterans diagnosed with both HF and diabetes.
  • Patients were stratified into quintiles (Q1-Q5) based on their HbA1C levels.
  • The study assessed the association between HbA1C quintiles and the risk of all-cause mortality and HF hospitalization over a 2-year follow-up period, with adjustments for confounders.

Main Results:

  • Mortality rates at 2 years showed a U-shaped pattern across HbA1C quintiles: Q1 (≤6.4%) 25%, Q2 (6.4%-7.1%) 23%, Q3 (7.1%-7.8%) 17.7%, Q4 (7.8%-9.0%) 22.5%, and Q5 (>9.0%) 23.2%.
  • The middle quintile (Q3, HbA1C 7.1%-7.8%) demonstrated significantly reduced mortality compared to the lowest quintile (Q1) after adjusting for confounders (aHR: 0.73; 95% CI: 0.61-0.88; p=0.001).
  • HF hospitalization rates increased with higher HbA1C quintiles, but this trend was not statistically significant after adjusting for confounders.

Conclusions:

  • The association between HbA1C and mortality in diabetic patients with HF exhibits a U-shaped curve.
  • The lowest risk of death was observed in patients with modest glycemic control, specifically HbA1C levels between 7.1% and 7.8%.
  • Further prospective research is warranted to establish precise optimal glycemic control targets for this patient population.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...